spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioProcess International West

BioProcess International West

19-22 March 2018

BioProcess International West (BPI West) is the leading phase-based bioprocessing event for advancing promising biologics towards commercial success.  Join 850+ global scientists and key decision makers at our upcoming meeting, held March 19-22, 2018 in San Francisco, CA. 

Keynote presenters on our 2018 agenda include Tony D’Amore (Sanofi Pasteur), Vijay Chiruvolu (Kite Pharma), and Arulvathani Arudchandran (FDA-CDER).

The BPI West 2018 agenda is comprised of four phase-based tracks, designed to bring attendees working across multiple departments together to collectively share challenges and discuss the solutions needed to improve the speed, lower the cost and increase the quality of biologics development.  

Register your team today and access 100+ case study and new data presentations across our four phase-based tracks:

  1. Single-Use/Flexible Facilities
  2. Early Stage Process Development
  3. Late Stage Process Development
  4. Commercial Manufacturing

Additionally, all attendees receive access to our exhibit hall which features 80+ global technology and service providers as well as 40+ peer-submitted scientific posters containing new and unpublished data. 

Save an extra 10% off current rates when you register with VIP code SAMEDANby February 9.  For full program details and to register, visit http://bit.ly/2F29qVt

Questions?  Contact Event Marketing Manager Howie Choi at howard.choi@knect365.com.
phone 888-670-8200 (U.S. Toll-free), +1 941-554-3500 (International)
email howard.choi@knect365.com
web bit.ly/2F29qVt
email Hilton San Francisco Union Square, San Francisco, CA
 
Print this page
Send to a friend
   
spacer
Industry Events

TAT 2018 – Targeted Anticancer Therapies

5-7 March 2018, Paris Marriott Rive Gauche Hotel & Conference Centre

The constant evolution of early phase development and translational research drove ESMO to enrich its meeting portfolio by acquiring the TAT Congress and providing a discussion platform focusing on new molecular targets and innovative cancer therapeutics.
More info >>

Banner of OCT Medical Devices Europe 2018_events_95 on Samedan

White Papers

Clinical Trial Labelling – More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>


News and Press Releases

Charles River Laboratories Acquires KWS BioTest

WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 11, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The addition of KWS enhances Charles River’s discovery expertise, with complementary offerings that provide our clients with additional tools in the active therapeutic research areas of oncology and immunology.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement